Paracetamol vs. Ibuprofen in Preterm Infants With Hemodynamically Significant Patent Ductus Arteriosus: A Non-inferiority Randomized Clinical Trial Protocol

Autor: Garcia-Robles, A, Navarro, AG, Martin, MDS, Quiles, MJP, Llorca, AP, Poveda-Andres, JL, Torres, MV, Carrascosa, MA

Publikováno v: Frontiers in pediatrics
r-IIS La Fe. Repositorio Institucional de Producción Científica del Instituto de Investigación Sanitaria La Fe
instname

Background: Currently, the first line treatment of persistent ductus arteriosus (PDA) is either indomethacin or ibuprofen. However, the potentially life-threatening side effects associated to their use have prompted physicians to look for alternative

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=RECOLECTA___::702b4b008553855557d78c71779e856e
https://fundanet.iislafe.san.gva.es/publicaciones/ProdCientif/PublicacionFrw.aspx?id=12678